Platelet Rich Plasma Market

Global Platelet Rich Plasma Market Size

The size of the global platelet rich plasma market was worth USD 386 million in 2024. The global market is anticipated to grow at a CAGR of 13.8% from 2025 to 2033 and be worth USD 1,234 million by 2033 from USD 439 million in 2025.

MARKET DRIVERS

Increasing Usage in Hair Loss, Sports Injuries, and Orthopedics

Increasing usage of PRP in various treatments such as hair loss, acute sports injuries, knee and thigh sprains, orthopedics, and others is primarily accelerating the growth of the global platelet-rich plasma market. The awareness among people regarding platelet-rich plasma applications in health applications is growing significantly, which is expected to result in market growth. As per the statistics published by the American Society of Plastic Surgeons in their 2018 Plastic Surgery Statistics Report, the usage of PRP treatment is expected to grow by 12% from 113,356 procedures in 2017 to nearly 127,394 procedures in 2018. In addition, the increasing investments from the governments of various countries in favor of PRP are another key factor contributing to the PRP market growth. In addition, the rising awareness levels among the public regarding the benefits associated with PRP, such as faster healing ability and reduced costs related to medical procedures, are expected to fuel the growth rate of the global market during the forecast period.

In addition, the growing patient population suffering from orthopedic diseases and the rising aging population worldwide are favoring the global platelet rich plasma market growth. Furthermore, the growing applications of platelet-rich plasma in regenerative medicine and surgical procedures are expected to duel the PRP market growth.

MARKET RESTRAINTS

Lack of Standardization and Regulations

Risks associated with PRP treatments are one of the major factors hampering the global PRP market growth. In addition, side effects associated with PRP treatment are inhibiting the growth rate of the global platelet rich plasma market. Lack of standardization and regulations, lack of clinical evidence, and high costs of PRP treatments are further impeding the global PRP market growth. The costs of PRP treatment are not covered in many countries. Hence, the lack of insurance coverage for PRP treatments is another obstacle to market growth. Issues associated with safety and competition from alternative treatment options are further expected to impact the worldwide PRP market growth negatively. The scarcity of skilled workforce that can operate PRP is another drawback to the market's growth rate.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Product Insights

Based on the product, the pure PRP segment accounted for the leading share of the platelet rich plasma market in 2024 because of less inflammatory responses and effective results in bone regeneration. In addition, pure PRP has a high concentration of platelets. The growing adoption of pure PRP in dental and orthopedic applications further propels segmental growth. In addition, the growing adoption of minimally invasive surgeries and rising awareness among healthcare providers and people regarding the advantages associated with Pure PRP is fuelling the segment's growth rate.

The Leukocyte-rich PRP segment is expected to rise at the fastest growth rate during the forecast period owing to its efficiency in healing soft tissue. PRP therapy is the go-to method for soft tissue healing and thus is projected to grow steadily in upcoming years. The growing usage of Leukocyte-rich PRP in treating sports injuries, tendonitis, and other soft-tissue conditions is one of the major factors promoting the segment's growth rate. In addition, the development of new leukocyte-rich PRP techniques is another notable factor supporting the segment's growth rate.

By Application Insights

Based on application, the orthopedics segment had the largest share of the global platelet rich plasma market in 2024, owing to the growing patient population suffering from orthopedic diseases worldwide. PRP is one of the population treatment options for orthopedic conditions such as osteoarthritis, tendinitis, and ligament injuries. PRP therapy is very effective in promoting bone healing and soft tissue.

In addition, the cosmetology segment is predicted to showcase a healthy CAGR during the forecast period owing to the rising demand for cosmetic surgeries worldwide. In addition, the rising concerns regarding appearances with the internet and social media penetration are fuelling the segment's growth rate. 

By Origin Insights

Based on the origin, the autologous PRPs segment is expected to dominate the market during the forecast period due to the applications of autologous PRPs in curing diabetic ulcers without any significant risks associated with the procedure. In addition, Autologous PRPs support the wound-healing process and have broad applications in fat grafting and maxillofacial surgeries. This treatment causes less blood loss and helps safe, fast, and effective procedures.

REGIONAL ANALYSIS

The North American platelet-rich plasma market accounted for the leading share of the global market in 2024. More significant developments in plasma therapy and an increasing number of orthopedic diseases have led to North America being the market leader. With the presence of key players and the increasing frequency of cosmetic surgeries and sports injuries, a growing number of people with orthopedic disorders are primarily driving the North American Market. The United States is leading the North American market due to government steps to develop blood products, followed by the Canadian market.

The platelet rich plasma market in Europe was the second-largest region in the global market in 2024 and showcased a promising growth rate during the forecast period. The U.K. market has been led by factors such as the limited existence of domestic manufacturers of PRP. France is the second largest in the PRP market and is estimated to maintain its position throughout the forecast period.

At the same time, the Asia-Pacific platelet rich plasma market is expected to rise steadily, with countries like India, China, and Japan contributing heavily to the global Platelet Rich Plasma Market. Growing awareness of the PRP market is to drive the market. Also, increasing investments in healthcare infrastructure, the amount spent on healthcare, a large population base with chronic bounds, and orthopedic disorders are responsible for the growth in this region. 

Over the forecast period, the Latin American platelet rich plasma market is projected to have a steady growth rate. The Brazilian market is accounted to have the maximum share of the PRP market wide range of PRP usage for applications like hair loss, knee, and thigh sprains accelerate the market. Mexico and Brazil are to make considerable investments to spread awareness regarding plasma therapy.

The Middle East & Africa platelet rich plasma market is deemed to have a moderate growth rate in the coming years. The growth is due to the government increase for the safe disposal of unused medications, and awareness about the safe disposal of pharmaceuticals and environmental conservation is likely to influence the PRP market growth.

KEY MARKET PLAYERS

Some key manufacturers leading the global platelet rich plasma market include DR. PRP AMERICA, LLC, Glofinn Oy, Zimmer Biomet, DePuy Synthes, Emcyte Corporation, Terumo BCT, Anthrex Inc, T-Biotechnology, and Stryker.

RECENT MARKET HAPPENINGS

• In March 2020, The EmCyte Company completed the acquisition of centrepid platelet concentrator from Cellmedix Holdings Inc. With this acquisition, the EmCyte Corporation has expanded its product portfolio and strengthened its distribution network. Also, the CEO of EmCyte was excited that this acquisition would boost its operations regarding biological creativity.
• In March 2020, Aesthetics Biomedical Inc. announced that it had acquired U.S. patents for Biologic Preserving Composition and Methods of Use. These patents are applied for integrations of skincare into biologics. 
• Researchers from a medical university in Dublin have collaborated with another medical university from Poland to analyze the efficacy of PRP as adjuvant therapy for VVF. The researchers confirmed that access to PRP injections is helpful for the surgical repair of recurrent VVF.

MARKET SEGMENTATION

This global platelet rich plasma market report has been segmented by product, application, origin, and origin.

By Product

• Pure-PRP
• Leukocyte-Rich
• Leukocyte-Rich Fibrin

By Application

• Orthopedics
• Cosmetic surgery
• Ophthalmic surgery
• Neurosurgery

By Origin

• Homologous PRP
• Autologous PRP
• Allogeneic PRP

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa